XINXIN TANG: Open Payments
NPI 1487087144 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$430 in 14 payments from 8 companies in 2025. Trend: 2023 $450 · 2024 $719 · 2025 $430
Food & beverage: $321Education: $109
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 2 | $142 |
| Karyopharm Therapeutics Inc. | 2 | $63 |
| Celgene Corporation | 2 | $56 |
| Exact Sciences Corporation | 2 | $48 |
| Exelixis Inc. | 2 | $45 |
| BTG International Inc. | 2 | $40 |
| ADC THERAPEUTICS AMERICA, INC. | 1 | $20 |
| Novo Nordisk Inc | 1 | $15 |
Products named: JAYPIRCA, XPOVIO, Cologuard Collection Kit, CABOMETYX, VORAXAZE, REBLOZYL, BREYANZI, ZYNLONTA.
Industry payments across TX — which companies pay providers there.
